Vexler Vladimir 4
4 · Coherus BioSciences, Inc. · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Vexler Vladimir
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-01+50,000→ 50,000 totalExercise: $17.60From: 2021-02-01Exp: 2031-02-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]On January 22, 2021, the compensation committee of the board of directors of Coherus BioSciences, Inc. approved the grant of an option to purchase 50,000 shares of common stock subject to the achievement of a certain performance milestone. 100% of the shares underlying this option were fully vested and exercisable at grant.